___

• I. Serruys PW. de .laeger P. Kiemcneij F et al. A comparison of balloon-expandable-stent imp- lantation with balloon angioplasty in patients with coronary heart disease. N Engl J Med ;33l:489—95. Fıt-StemRes'renavit 42 I. Fischman DL. Leon MD. Baim DS et al. A randomized comparison ot‘coronary-stent pla- eement and balloon angioplasty in treatment of coronary artery disease. N Engl J Med |994233lz49o—Sş|.
• Mehran R. Dangas G. Abizaid A S. ct al.. “Angiograpl'tic patterns of in—stent restenosis. ClassiŞcation and implications for long-term outcome". Circulation. 199 [1999}. pp. LEITZ—S.
• Cardiovasc lnterv. 1999. 48. lilo-323.
• Bonnier J J R M. Stent coating or brachy— therapy? Their future role in cndovascular the- iht’mne Hi. .-"ı"um.üı;n' _?_ 2ı9ı9ı'î rapy of coronary artery disease. Progress in Bi— omedical Research. zoao. 229-232. Rogers C. Edelman E R. Ende-vascular stcnl design dictates experimental restenosis attd thrombosis. Circulation. 266l. 9l. 2995- 3661.
• I?. Kcrciakes D J. Cox D A. Hermiller J E. et aI.. Usefulness of a cobalt chromium coronary stent alloy. Ant J Cardiol. 2663. 92. 463—466.
• Ciıtlip D E. Chauhan M S. Baim D S. et al.. “Clinical resıenosis after coronary stcnting: perspectives frotn multiccntcr trails”. J Am Coll Cardicl. 4a {zoos}. pp. Loss—sı. Farb A. Weber D K. Kolodgie F D. et al.. “Morphological predictors of restenosis alter coronary stenting in humans“. Circulation. 165 pp. 2.932—3. Serruys P W. van l-iout E Bonnier H. Leg- rand ‘v’. et aI.. Randomized comparison oF imp— lantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease {Benestent ll}. Lancet. 1993. 352. T3F63I.
• |. Reinters E. Moussa [. Akiyama T. et aI.. “Long-term clinical Fellow—up after successful repeat pcreutaneotts intervention for stent reste- nosis“. J Am Coll Cardiol. 36 “9921. pp. lil—6 92.
• Dauerman ll L. Baim D S. Cutlip D E. et al.. hllvtecl'tanical debulking versus balloon angi— oplasty for the treattnent of diffuse in-stent res- tenosis".An1J Cardiol. 62 (1996). pp. ETT—64.
• Albiero R. Silber S. Di Mario C. et al.. “The RESCUT Investigators. Cutting balloon verses conventional balloon angioplasty for the treat- ment ol'in—sıent restenosis: results ol‘ the reste— ııosis eutting balloon evalttation trial [RES- CUTl". J Am Coll Cardiol. 43 [2664]. pp. —9.
• Harrington R A. Lineott‘A M. Caliş'R M. et al.. “Characteristics and consequences of myo- cardial infarction after percutaneous coronary intervention: insights front the Coronary Angi- oplasty 'v’ersus Excisional Atherectomy Trial {CAVEATTZ J. Am. Coll. Cardiol.. 25 {I995}. pp. l.693—9. McKenna C J. Wilson S H. CantrudA R. et al.. “Neointintal response following rotatiottal athereetomy compared to balloon angioplasty in a porcine model of coronary in-stent resteno- A'ns'tş'et'u Hero-r Journal sis“. Cathet Cardiovasc Diagn. 45 [1996]. pp. —6.
• Sliamta S K. Duvvuri S. Dangas G. et aI.. ”Rotational atlterectotny for in-stent restenosis: acute and Iongwtcrm results of the Şrst lşş ca— ses“. J Am Coll Cardiol. 32 [1993]. pp. 358—65.
• T. vom Dahl J. Dictz U. Hanger P K. et al. for the ARTIST Investigators. “Rotational athercc- tomy does not reduce recurrent in-stent resteno- sis. Results of the angioplasty versus rotational athereetomy for treatment of diffuse in—stent restenosis trial {ARTIST)"". Circulation. [65 (zoos). pp. ass—s. 38. Shanna S K. Kini A. Mehran R. et al.. “Ran- domized trial of rotational atherectorny versus balloon angioplasty for diffuse in-stent resteno- sis {RDSTER}". Am Heart J. 14? (26641. pp.]6—22.
• Waksman R. White R L. Chan R C. et aI.. ”lntracoronary gamma-radiation tltetapy after angioplasty inhibits recurrence in patients with in-stent restenosis". Circulation. 161 [2666]. pp. lids-TI.
• Malhotra S and Teirstein P S. “The SCRPPS trial — Catheter-based radiotherapy to inhibit coronary restenosis". J [nv Cardiol. IE (2666). pp. 336—2.
• Waltz-iman R. While R L. Chan R C. et aI.. “Intraeoronary gamma-radiation therapy after fir-StemRestermsfs 44 angioplasty inhibits recurrence in patients with in-stent restennsis“. Circulation, IÜI [2000}. pp. lifti—Tl.
• Leen M B. Tierstcin P S. Moses J W. et al.. “Localized intracoronary gamma-radiation the— rapy to inhibit tltc recurrence of restenosis after stenting". N Engl J Med. 344 {20011. pp. ESG—ft. 4T. Waksn‘tan R. Bhargava B. White L. ct al.. "lntracoronary betanradiation tltcrapy inhibits recurrence of in-stent restenosis“. Circulation, 101 {seen}. pp. Lass—s.
• Wardeh A J. Kay l P. Sabatc M. et al.. “13e- ta—particle—emitting radioactive stent implanta— tion. A safety and feasibility study". Circulati- on. 100 [ I999). pp. I.t'iS=l—9. Waksman R. Mani A E. White R L. et al.. “Intravascular radiation for in—stent restenosis in saphenous vein bypass graft". N Eng] J Med. :2002}. pp. l.l94—9.
• Waksman R. Ajani A E. Pinnow E. ct al.. “Twelve versus six months of clopidogrc] te re— duee eardiae major events in patients undergo- ingnradiatien therapy for invstent restenosis: Washington Radiation for ln-Stent Trial {WRIST} 12 versus WRIST PLUS". Circulati- on. Ice {zoos}. pp.Tio---E. |. Baron J ll. Gersltlick A li. l'legret'e K. et al..ln vitre evaluation of cTE3aFab [ReoPro] eluting pelymer—eeated eerenary stents. Cardio- vasc Res. 2000. as. 535—594. ilardltammar P A. van Betlsckom H M.
• Emanuelsson H U. ct al.. Reduction in throin— botie events with heparin-coated Palmaz- Schatz stems in normal porcine coronary arteri— es. Circulation. 1996. 93. 423-430.
• De Schcerdcr 1. Wang K. Witezek K. et al.. Experimental study ofthrombogenicily and fo- reign body reaction induced by heparin—coated coronary stents. Circulation. l997. 95. [549— I553. Ahn Y K. Jeeng M H. Kiın J W. et al.. Pre- ventive effects of tlte heparin-coated stent on restenosis in the porcine model. Catheter Car— diovasc lnterv. 1000. 48. 324-330.
• Matsumoto Y. Sbimokawa H. Morishige K. et al.. Reduction iIt neointimal formation with a stent coated witlt multiple layers of releasable heparin in porcine coronary arteries. J Cardio- Iu—Hrerır Resmim-riv vase Pharmacoi. 2002. 39. 5 13—522.
• Sü. ‘v‘rolix M C. Legrand "v“ M. Reiber J H. et al.. Heparin—coated | IE- Current Drug Targets — Cardiovas. & Haentat Dis. 2004. Vol. 4. No. l
• FroeSchl ct al. Wilttor stents in human coronary arteries {MENTDR trial}. MENTDR Trial ln- vestigaters Am J Cardiol. 2000. 86. 335-389.
• ST. ‘v’an Langenhove Ci. 1v’ermecrsclt P. Serrano H P. et al.. Saphcnous vein graft disease treated with the Wiktor Hepamcd stent: procedural out- come. in-hospital complications and six-month angiographic t'elletv—up. Can. J Cardiol. 2000. ıs. 4T3-4SÜ.
• Shirt E K. Sen .l W. Sohn M S. et al.. Ef‘ti— cacy of heparin-coated stent in early setting of acute myocardial infarction. Catheter Cardio— vasc lntcrv. 200]. 52. 306-312. Grines C L. Cox D A. Stone G w. et al.. Coronary angioplasty with or without stettt implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial ln- farction Study Group. N Engl J Med. |999. Ili—"494956. ül]. Buller C E. Dzavilt V. Carcre R G. et al..
• Primary stcnting versus balloon angioplasty in occluded coronary arteries: the Total Occlusion Study ofCanada {TDSCA}. Circulation. 1999. 236-242 til. Wobrle .1. A1 Khayer E. Grotzinger U. ct al..
• Comparison ofthe heparin coated vs the uncoa- ted Jostent—-ao inşuence on restenosis or clini— cal outcomc. Eur Heart .1. 200]. 22. ISUS-lŞlo De Scheerder [. Wang K. Wilczclr K.et al.. Local methylprcdnisolone inhibition of foreign body response to coated intracoronary stents. Coron Artery Dis. 1996. T. let-tee. 53. Muller D W. Goiontb G. Gordon D. Levy R
• Chung [ M. Gold H K. Schwartz S M. [kari 't'. Reidy M A. WightT N. Enhanced extracellu— lar matrix accumulation itt restenosis of coro- nary arteries after stent deployment. J Am Coll Cardiol. 2992. 49. 2922—2931
• Hankc H. Kamenz J. Hassenstein S. Prolon- ged prolil‘eralive response ol” smooth musclc cells after experimental intravascular stenting. Eur Heart J. 1995. lo. 21-15—1193.
• Mars 8 Ü. Jayaraman T. Cio L 0. Marks A R. Rapamyein— FKBP inhibits cell cycle regula— tors of proliferation in vascular smooth mttscle cells. Cire Res. I995. re. 412—412. as. Poott M. Mars S Ü. Gallo R. Badimon J J. Tauhtnan M B. Marks a R. Rapamyein inhibits vascular smooth muscle cell migration. .1 CIin invest. 1996. 93. 2222—2233.
• Tü. Burke S E. Luhhcrs N L. Chen Y W. Hsieh Ct. Mollison K W. Luly J R. Wegner C I}. Nc— ointiınal formation after balloon-induced vas- cular injury in 1t’ucatan minipigs is reduced by oral rapamycirt. J Cardiovasc Phartrtacol. 1999. 829-335.
• Tl. Sousa J E. Costa M A. Ahizaid A S. ct a1.. Sustained suppression ofneointimal proliferati- on hy sirolitnus‘eluting stents. Circulation. 194. 2992- 2911.
• TI. Moscs JW. Leon M El. PoptnaJ J. et a1.. Si— rolimus-eluting stents versus standard stents in patients with stenosis in a native coronary ar— tery. N Engl . Med. 2993. 349. 1315-1323.
• '1'3. Holmes D R Jr. Leon M B. Moses J W. ct al.. “Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial ofa sirolimus— cluting stcrıt versus a standard stent in paticttts at high risk for coronary restenosis". Circulatir on. 199 {Zena}. pp. est-en. Brara P S. Moussavian M. Crrise MA. ct al.. Pilot trial oforal rapamycin for recalcitrant ros- tcnosis. Circulation. 2993. 192. 1222-1224.
• TS. Rowinsky E K. Donehower R C. Paclitasel (tamil. N Engl J Med. 1995. 332. 1994-1914. ts. Park S .1. Shim W H. Ho D S. ct al.. .4. Pac—
• Iitach-Eluting Stent for the Prevention of Coro- nary Restenosis N Engl J Med. 2993. 3453. 1545.
• Koşuyolu Heart Journal '.t'l'. Hong M K. Mint: (] S. Lee CW. et a1.. Pac— litaxcl coating rcdttccs in-stcnt intimal hyperp- lasia in human coronary arteries: a serial volu— metric itttravascular ttltrasound analysis from the ASian Paclitaxel-Eluting Stcnt Clinical Tri— al {ASPECT}. Circulation. 2993. 192. 512-5211.
• Lim ‘v’ Y T. Lim Y T. Rcstcnusis in percuta— neous coronary intervention - [s drug—cluting stcnt tlıc answer? Singapore Med J. 2993. 4-4. —437.
• Gruhe E. Siiher S. I'lauptmann K E. et a1.. TAXUS 1: Six— and Twelve—Month Results From a Randomized. Double-Blind Trial on a Slow— Release Paclitaxel—Eluting Stent for De Novo Coronary Lesions. Circulation. 2993. 313—42.
• Colombo A. Drzewiecki J. Banning A. et a1.. “Randomized study to assess the effective— ness of slow- and moderate release polymer-ha- sed paclitaxel—eluting stents for coronary artery lesions". Circulation. 198 {2993]. pp. 238—94.
• Bl. Drachman D E. Clinical experience with drug-clutittg stents. Rev Cardiovasc Med. 2992. Suppl. 5. 531532.
• Alhicro R. Nishida T. Adamian M. ct al.. Edge restenosis after implantation of high acti- vity [32]? radioactive beta-emitting stents. C ir- culation. 2999. I91. 2-‘45-‘4-2451Ir
• Sahate M. Costa M A. Kozan-ta K. ct al.. Geographic miss: a cause of treatment failure in radio—oncology applied to intraeoronary radiati— on therapy. Circulation. 2999. 191. 2462-2421.
• Kim H S. Waksman R. Cottin Y.et al.. Edge stenosis and geographical miss following intra- coronaryr gamma radiation therapy for in—stent restenosis. 1.4m Coll Cardiol. 2991. 32. 1926
• Scrrttys P W. chcrtckin M. Tattahc K. ct a1.. lntravascular ultrasound Current Understan— ding of [lSRl and the Potential BeneŞt of DESs] Current Drug Targets - Cardiovas. & Hacmat. Dis.. 2994. Vol. 4. No. II'ir findings in the multicentcr. randomized. double-blind
• RAMEL [Randomized study with the sirolimus— cltıting ‘v'Elocity balloonexpandahle stcnt in the treatment of patients with de novo native coro— nary artery Lcsions] trial. Circulation. 2992. t'ı. 298—393.
• Cos H R. Popma J J. Prpic R. Kuntz R. Mo- thsŞ'rerrrşesrermstir 46 ses J w, Leon M B. Does ”Geographic Miss" account for peri-stent restenosis in patients tın— dcrgoing Sirolimus-cluting Bx 1rclocity stcnt implantation? Circulation. ZÜÜE. lilo. 11-5]? {abstract}. S'i'. Sousa .l E. Ahizaid A. Fercs F. et al.. Late (three—year) followup From the First-in Mart (FIM) experience after implantation of siroli- mus-cluting stcnts. Circulation, 20432. IBIS, ll- {abstract}.
• Farh A. Heller P F. SItrofî'S. et al.. Patholo- gical analysis of local delivery of paclitaxcl yi— a a polymer—coated stent. Circulation. Ztltll. lş4. 4?3—4?9. Kataoka T. Grttbe E. Honda Y. ct al.. "t"-Ite- xauoyltaxol-cluting stent for prevention of nc- ointimal growth: an intrauascuiar ultrasound analysis l'rom tlte Study to Cümpare REsteno— sis rate between QucST and QuaDS—QPE {SCORE}. Circulation. 20132. lütfi. 17"384793. It:—Hmm Hayrana-riv t}. Heldman AW. Chang L. Jenkins M, et al.,
• Paclitaxcl stent coating inhibits ncointimal liypcrplasia at 4 weeks in a porcinc tnodcl of coronary rcstcnosis. Circulation. îüül. 1-33. 2195.